9.05
price up icon0.44%   0.04
after-market Handel nachbörslich: 9.05
loading

Organon Co Aktie (OGN) Neueste Nachrichten

pulisher
Aug 12, 2025

Organon: Valuation Discount Offset By Structural Headwinds (NYSE:OGN) - Seeking Alpha

Aug 12, 2025
pulisher
Aug 12, 2025

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - uk.finance.yahoo.com

Aug 12, 2025
pulisher
Aug 11, 2025

Natixis Advisors LLC Has $778,000 Holdings in Organon & Co. (NYSE:OGN) - Defense World

Aug 11, 2025
pulisher
Aug 10, 2025

Organon & Co. (OGN): Assessing Dividend Sustainability and Valuation Amid Earnings Pressures and Strategic Catalysts - AInvest

Aug 10, 2025
pulisher
Aug 10, 2025

Read This Before Considering Organon & Co. (NYSE:OGN) For Its Upcoming US$0.02 Dividend - uk.finance.yahoo.com

Aug 10, 2025
pulisher
Aug 08, 2025

Organon & Co. (OGN) Reports Q2 2025 Results - MSN

Aug 08, 2025
pulisher
Aug 08, 2025

Organon Q2 Preview: What to expect? - MSN

Aug 08, 2025
pulisher
Aug 08, 2025

Organon & Co. (NYSE:OGN) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

Aug 08, 2025
pulisher
Aug 07, 2025

Organon & Co. (NYSE:OGN) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year - Yahoo Finance

Aug 07, 2025
pulisher
Aug 07, 2025

Organon & Co. Reports Q2 2025 Financial Results - The Globe and Mail

Aug 07, 2025
pulisher
Aug 06, 2025

Organon & Co. Earnings Call: Resilience Amid Challenges - The Globe and Mail

Aug 06, 2025
pulisher
Aug 06, 2025

Organon (OGN) Fiscal Q2 Revenue Beats 1% - AOL.com

Aug 06, 2025
pulisher
Aug 06, 2025

Organon & Co. (OGN) Slashes 13.13% on Disappointing Earnings - MSN

Aug 06, 2025
pulisher
Aug 06, 2025

Organon Q2 Earnings: It May Be Time To Desert This Sinking Ship (Downgrade) (NYSE:OGN) - Seeking Alpha

Aug 06, 2025
pulisher
Aug 06, 2025

Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences - The Globe and Mail

Aug 06, 2025
pulisher
Aug 06, 2025

Organon & Co. SEC 10-Q Report - TradingView

Aug 06, 2025
pulisher
Aug 06, 2025

Organon & Co. (NYSE:OGN) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 06, 2025
pulisher
Aug 06, 2025

Organon Reports Results for the Second Quarter Ended June 30, 2025 - BioSpace

Aug 06, 2025
pulisher
Aug 06, 2025

Organon & Co (OGN) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth By GuruFocus - Investing.com Canada

Aug 06, 2025
pulisher
Aug 05, 2025

Organon: Q2 Earnings Snapshot - Norwalk Hour

Aug 05, 2025
pulisher
Aug 05, 2025

Organon raises 2025 revenue guidance by $100M amid Vtama ramp and debt reduction focus - MSN

Aug 05, 2025
pulisher
Aug 05, 2025

Organon & Co To Go Ex-Dividend On August 15th, 2025 With 0.02 USD Dividend Per Share - 富途牛牛

Aug 05, 2025
pulisher
Aug 05, 2025

Organon reports Q2 adjusted EPS $1.00, consensus 94c - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

Organon raises FY25 revenue view to $6.28B-$6.38B from $6.13B-$6.33B - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

OGN Shares Plunge: Lawsuit Drives Market Shock - StocksToTrade

Aug 05, 2025
pulisher
Aug 05, 2025

Organon & Co. 2025 Q2ResultsEarnings Call Presentation (NYSE:OGN) - Seeking Alpha

Aug 05, 2025
pulisher
Aug 05, 2025

Earnings call transcript: Organon Q2 2025 beats EPS expectations, stock volatile - Investing.com

Aug 05, 2025
pulisher
Aug 05, 2025

Organon Becomes Oversold - Nasdaq

Aug 05, 2025
pulisher
Aug 05, 2025

Organon (OGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

Organon & Co. Reports Strong Q2 Earnings, Surpassing ExpectationsNews and Statistics - IndexBox

Aug 05, 2025
pulisher
Aug 05, 2025

Organon surpasses expectations with $1.59B revenue in Q2 2025 - grafa.com

Aug 05, 2025
pulisher
Aug 05, 2025

Organon's Strategic Path to Financial Stability and Dividend Resumption - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

Organon Q2 2025 slides: Revenue guidance raised amid Women’s Health strength - Investing.com Australia

Aug 05, 2025
pulisher
Aug 05, 2025

Organon (OGN) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

Organon jumps despite Q2 revenue dip as revised outlook exceeds consensus - MSN

Aug 05, 2025
pulisher
Aug 05, 2025

Organon Q2 Adjusted Earnings, Revenue Fall, Beat Estimates; 2025 Revenue Guidance Raised - MarketScreener

Aug 05, 2025
pulisher
Aug 05, 2025

Organon stock jumps after Q2 revenue beat (OGN:NYSE) - Seeking Alpha

Aug 05, 2025
pulisher
Aug 05, 2025

Organon (NYSE:OGN) Surprises With Q2 Sales, Stock Soars - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

Organon shares surge over 8% as Q2 earnings top estimates, raises revenue outlook By Investing.com - Investing.com South Africa

Aug 05, 2025
pulisher
Aug 05, 2025

Organon shares surge over 8% as Q2 earnings top estimates, raises revenue outlook - Investing.com India

Aug 05, 2025
pulisher
Aug 05, 2025

Organon Co earnings beat by $0.06, revenue topped estimates - Investing.com Australia

Aug 05, 2025
pulisher
Aug 05, 2025

Earnings Snapshot: Organon new revenue outlook beats estimates after strong Q2 (OGN:NYSE) - Seeking Alpha

Aug 05, 2025
pulisher
Aug 05, 2025

Organon in charts: Women's Health revenue up ~3% Y/Y in Q2 (NYSE:OGN) - Seeking Alpha

Aug 05, 2025
pulisher
Aug 05, 2025

Organon beats Q2 revenue expectations, raises FY guidance - MarketScreener

Aug 05, 2025
pulisher
Aug 05, 2025

Earnings Flash (OGN) Organon & Co. Reports Q2 Revenue $1.59B, vs. FactSet Est of $1.55B - MarketScreener

Aug 05, 2025
pulisher
Aug 03, 2025

Organon Earnings: What To Look For From OGN - Yahoo Finance

Aug 03, 2025
pulisher
Aug 03, 2025

Organon & Co. (OGN) Expected to Announce Earnings on Tuesday - Defense World

Aug 03, 2025
pulisher
Aug 01, 2025

Insights Into Organon (OGN) Q2: Wall Street Projections for Key Metrics - Yahoo Finance

Aug 01, 2025
pulisher
Jul 31, 2025

Organon (OGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance

Jul 31, 2025
drug_manufacturers_general SNY
$48.05
price up icon 1.78%
drug_manufacturers_general PFE
$24.65
price up icon 0.28%
$120.02
price down icon 0.37%
$284.98
price down icon 0.04%
drug_manufacturers_general NVO
$49.78
price down icon 0.18%
drug_manufacturers_general MRK
$80.30
price up icon 0.34%
Kapitalisierung:     |  Volumen (24h):